BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Kidney
,
Avian flu virus
,
Fluoxetine
,
rs7903146
,
FABP1
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Interleukin-4/interleukin-13
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Basophil of peripheral blood
Uterus
Myometrium
Corpus callosum
Nipple cross-section
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
11p partial monosomy syndrome
Infection by Nippostrongylus
IgE-mediated allergic disorder
Legionella infection
Eczema
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
enterotoxin I, staphylococcal
Allergens
TX 522
grass pollen extract, alum-adsorbed
phorbolol myristate acetate
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Jak2
BACH2
KLRC1
MTOR
ANG
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Th17 cells deficient for Sgk1 and treated with IL23
Monocytes derived from blood treated with TLR10 stimulatory antibody and/or lipopolysaccharides
Dominant Th2 differentiation of regulatory T cells upon loss of FOXP3 expression
CD3+ T-cells from wildtype and KLF13 KO mice
CD4+ T cells activated by PHA/IL-2 or anti-CD3/CD28 compared to resting T cells
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Interleukin-4/interleukin-13
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HIV Reservoir Reduction With Interleukin-2
Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients
Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ